EPTIS
BAM Logo

Immunohistochemistry Lymphoma Markers

EPTIS factsheet 780664 | Last revision 2020-12-02 | URL: https://www.eptis.bam.de/pts780664 https://www.eptis.bam.de/pts780664

PT provider
PT provider RCPAQAP RCPAQAP
Based in Australia
Language(s) English
Remarks
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Unstained formalin fixed paraffin sections comprising of composite tissue block to be stained for 3 lymphoma markers. CD4 (alternate CD8) -
CD43 (alternate CD5) -
BOB-1 (alternate Bcl-2) -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by NATA on the basis of Accreditation by NATA on the basis of ISO/IEC 17043:2010

Operation is commissioned / requested by
Fees and frequency
Participation fee Yes
Regularly operated Yes (3 cases per survey/1 surveys)
Year of first operation
Contact details of the PT provider
Provider Contact person
RCPAQAP
Suite 201/8 Herbert Street
St Leonards, 2065
Australia

Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Web: https://www.rcpaqap.com.au/ https://www.rcpaqap.com.au/
Mr Rhys Judd
Phone: (61 2) 9045 6000
Fax: (61 2) 9356 2003
Email: rhys.judd@rcpaqap.com.au rhys.judd@rcpaqap.com.au
If you find any mistakes please contact the responsible EPTIS coordinator in Australia, Ms Luminita Antin. Ms Luminita Antin.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21